CapForce IBD Breakout Opportunities ETF
BOUT
8 hedge funds and large institutions have $1.23M invested in CapForce IBD Breakout Opportunities ETF in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.
9.23% less ownership
Funds ownership: 18.48% → 9.24% (-9.2%)
20% less funds holding
Funds holding: 10 → 8 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
49% less capital invested
Capital invested by funds: $2.41M → $1.23M (-$1.18M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$372K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$220K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$57K |
| 4 |
HCM
Hollencrest Capital Management
Newport Beach,
California
|
+$8.72K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$1.06M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$409K |
| 3 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$353K |
BOUT Hedge Fund Activity: Q4 2022 in Review
8 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q4 2022, worth a combined $1.23M — down 49% from $2.41M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BOUT and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.
The largest buyer was Citadel Advisors, adding an estimated $372K. The largest seller was Harbour Investments, exiting entirely with an estimated $1.06M sold.
- 8 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q4 2022, down from 10 in Q3 2022.
- Funds reported $1.23M of CapForce IBD Breakout Opportunities ETF stock for Q4 2022, down 49% quarter-over-quarter.
- 2 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q4 2022 and 3 closed out, a net change of -1 holder.
- The largest CapForce IBD Breakout Opportunities ETF buyer in Q4 2022 was Citadel Advisors, an estimated $372K added.
- The largest CapForce IBD Breakout Opportunities ETF seller in Q4 2022 was Harbour Investments, an estimated $1.06M sold.
Based on aggregated 13F filings for Q4 2022.